DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mesantoin (Mephenytoin) - Summary

 
 



MESANTOIN SUMMARY

Mesantoin®

Mesantoin® (mephenytoin) is 3-methyl 5,5-phenyl-ethyl-hydantoin. It may be considered to be the hydantoin homolog of the barbiturate mephobarbital.

Mesantoin (mephenytoin) is indicated for the following:

For the control of grand mal, focal, Jacksonian, and psychomotor seizures in those patients who have been refractory to less toxic anticonvulsants.



See all Mesantoin indications & dosage >>

NEWS HIGHLIGHTS

Published Studies Related to Mesantoin (Mephenytoin)

Identification of New CYP2C19 Variants Exhibiting Decreased Enzyme Activity in the Metabolism of S-Mephenytoin and Omeprazole. [2009.11]
Although many cases of interindividual variation in the metabolism of CYP2C19 drugs are explained by the CYP2C19*2, *3, and *17, a wide range of metabolic variation still occurs in people who do not carry these genetic variants. The objectives of this study were to identify new genetic variants and to characterize functional consequences of these variants in metabolism of CYP2C19 substrates...

more studies >>

Clinical Trials Related to Mesantoin (Mephenytoin)

Metabolic Capacity of Israeli Populations [Terminated]
The ability to metabolize drugs varies greatly among individuals. Major fraction of this variability lies in genetic polymorphisms of genes encoding for enzymes responsible for both phase I and phase II reactions. The purpose of this study ws to evaluate the phenotypic activity and the frequency of genetic polymorphisms in different phase II and phase I enzymes among various populations residing in Israel.

more trials >>


Page last updated: 2009-10-20

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015